Top Healthcare Stocks
Healthcare stocks are little changed this afternoon with the
NYSE Healthcare Sector Index rising about 0.1% while shares of
healthcare companies in the S&P 500 currently are down less
than 0.1% as a group.
In company news, Echo Therapeutics (
) is closing strongly today, with shares rising to their best
levels since early May after the medical device manufacturer said
its Symphony CGM continuous glucose monitoring system met primary
safety and effectiveness endpoints in a new clinical trial.
During the trial, the Symphony device produced clinical accurate
readings in 97.9% of the times it was used while benign errors
occurred at a 1.8% pace, creating an overall accuracy rate of
ECTE said data collected from this study will serve as the basis
for the company's CE Mark technical file submission for marketing
approval in Europe, which ECTE expects to file before the end of
In other sector news,
(+) MACK, Drug-maker reports promising results from a pair of
clinical studies of its MM-121 in patients with certain types of
breast cancer. MACK also announced a collaboration pact with
Actavis plc (
) to develop and commercialize new drugs.
(-) GHDX, Acquires rights to further develop and commercialize
Almac Group's multi-gene test to predict benefit from DNA
damage-based chemotherapy drugs for breast cancer in exchange for
$9-mln upfront payment and future milestone, royalty payments.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.